Related Experiment Video
Updated: Nov 5, 2025

08:22
Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids
Published on: August 11, 2017
16.1K
Biofabrication of tissue engineering vascular systems
Qiao Zhang1, Èlia Bosch-Rué2, Román A Pérez2
1Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708, USA.
APL Bioengineering
|May 13, 2021
Summary
Tissue engineered vascular systems (TEVS) offer promising solutions for cardiovascular disease (CVD) treatment and in vitro disease modeling. Advances in biofabrication and biomaterials are crucial for developing TEVS that mimic native vessels.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cardiovascular Research
Background:
- Cardiovascular disease (CVD) is a primary cause of mortality in developed nations, particularly among older adults.
- Tissue engineered vascular systems (TEVS) are being developed as potential grafts for CVD treatment.
- TEVS also serve as valuable in vitro models for studying genetic factors in CVD progression.
Purpose of the Study:
- To review the mechanical and biological design requirements for TEVS.
- To explore advancements in biofabrication techniques and biomaterials for TEVS.
- To discuss the in vitro applications of TEVS, especially for disease modeling.
Main Methods:
- Literature review of biofabrication methods for TEVS.
- Analysis of biomaterials used in tissue engineering of vascular systems.
- Examination of in vitro applications and disease modeling capabilities of TEVS.
Main Results:
- Current TEVS fabrication aims to replicate native vessel mechanical properties and extracellular matrix.
- Progress in biofabrication and biomaterials is essential for TEVS development.
- TEVS show significant potential for in vitro cardiovascular disease modeling.
Conclusions:
- TEVS development requires careful consideration of mechanical and biological design principles.
- Innovations in biofabrication and biomaterials are key to improving TEVS functionality.
- In vitro applications of TEVS are expanding, offering new avenues for CVD research.

